相关实验视频
Updated: Jun 14, 2025

Assessing Whole-Body Lipid-Handling Capacity in Mice
Published on: November 24, 2020
缩小治疗脱脂症指南与临床实践之间的差距:我们现在处于何处?
Sohum Sheth1, Maciej Banach2,3, Peter P Toth3,4
1University of Florida College of Medicine, Gainesville, FL, USA.
实现低密度脂蛋白胆固醇 (LDL-C) 目标仍然是一个挑战,影响动脉样硬化心血管疾病 (ASCVD) 风险. 改善LDL-C目标的实现对于公共健康和心血管事件的减少至关重要.
科学领域:
- 心血管医学 心血管医学
- 脂质学 脂质学是指脂质学.
- 公共卫生 公共卫生
背景情况:
- 几十年的研究证实了低密度脂蛋白胆固醇 (LDL-C) 与动脉样硬化心血管疾病 (ASCVD) 风险之间的联系.
- 尽管制定了指导方针,但在初级和二级预防中,LDL-C目标实现率显著低.
- 不理想的启动,强化和坚持降脂疗法有助于弥补这一差距.
研究的目的:
- 为了突出LDL-C目标实现率较低.
- 为了确定与临床医生相关的因素和阻碍有效治疗失脂症的系统障碍.
- 强调增加LDL-C目标的公共卫生必要性,以减少心血管风险.
主要方法:
- 对当前关于LDL-C管理的文献和临床指导方针的审查.
- 分析导致低于最佳的降脂疗法的因素.
- 讨论改善患者治疗结果和患者遵守的策略.
主要成果:
- 在患者群体中,低水平的LDL-C目标实现率持续存在.
- 临床惯性,不一致的风险评估和接入障碍阻碍了有效的治疗.
- 降低LDL-C与降低心血管事件风险直接相关.
结论:
- 重新思考失脂症管理是必不可少的,需要多方利益相关者的方法.
- 实施LDL-C测量作为卫生系统指标,并鼓励预先组合治疗是关键策略.
- 利用药剂师,远程医疗和EMR可以提高治疗的有效性和坚持.
更多相关视频
09:15Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
Published on: November 10, 2017
07:29Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
Published on: October 12, 2017
相关概念视频
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Lipids: Dietary Sources and Requirements
Cholesterol: Significance and Regulation
Considering cholesterol and...
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...